Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar;10(3):1265-1268.
doi: 10.21037/jtd.2018.03.28.

Extending the curve: survival of EGFR-mutated lung cancer patients in the 21st century

Feliciano Barrón  1 , Zyanya Lucia Zatarain-Barrón  1 , Andrés F Cardona  2   3 , Oscar Arrieta  1
Affiliations
Editorial

Extending the curve: survival of EGFR-mutated lung cancer patients in the 21st century

Feliciano Barrón et al. J Thorac Dis. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Updated treatment algorithm for EGFR-mutated lung cancer. EGFR, epidermal growth factor receptor.
See this image and copyright information in PMC

Comment on

  • Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
    Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators. Soria JC, et al. N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137. Epub 2017 Nov 18. N Engl J Med. 2018. PMID: 29151359 Clinical Trial.

References

    1. Arrieta O, Guzman-de Alba E, Alba-Lopez LF, et al. National consensus of diagnosis and treatment of non-small cell lung cancer. Rev Invest Clin 2013;65 Suppl 1:S5-84. - PubMed
    1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. 10.3322/caac.21262 - DOI - PubMed
    1. Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med 2005;172:523-9. 10.1164/rccm.200504-531OE - DOI - PubMed
    1. Barron F, de la Torre-Vallejo M, Luna-Palencia RL, et al. The safety of afatinib for the treatment of non-small cell lung cancer. Expert Opin Drug Saf 2016;15:1563-72. 10.1080/14740338.2016.1236910 - DOI - PubMed
    1. FDA. Erlotinib LABEL. Available onine: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lb...